Zealand Pharma A/S Ord (ZLDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 977,288 | 1,070,224 | 1,100,954 | -47,317 | -156,430 |
| Depreciation Amortization | 4,144 | N/A | 1,851 | 841 | 3,748 |
| Accounts receivable | -13,363 | N/A | -22,366 | -621 | -7,099 |
| Accounts payable and accrued liabilities | -27,000 | N/A | -716 | -1,478 | 13,038 |
| Other Working Capital | -55,084 | -68,501 | -41,497 | -25,299 | 17,745 |
| Other Operating Activity | 102,950 | 184,483 | 181,392 | 3,213 | -5,969 |
| Operating Cash Flow | $988,935 | $1,186,206 | $1,219,618 | $-70,662 | $-134,968 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -333,543 | -294,338 | -156,324 | 79,492 | -1,061,366 |
| PPE Investments | -1,475 | -2,587 | -1,959 | -911 | -1,458 |
| Purchase Sale Intangibles | -5,406 | -409 | -398 | -325 | -449 |
| Other Investing Activity | -5,406 | 3,291 | 3,196 | -325 | -449 |
| Investing Cash Flow | $-340,424 | $-293,635 | $-155,087 | $78,257 | $-1,063,273 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 53,631 |
| Common Stock Issued | 7,441 | 5,094 | 4,659 | 500 | 1,235,904 |
| Common Stock Repurchased | -61,646 | -63,763 | -50,559 | N/A | -51,016 |
| Other Financing Activity | -3,053 | -2,221 | -1,333 | -612 | -36,688 |
| Financing Cash Flow | $-57,257 | $-60,889 | $-47,233 | $-112 | $1,201,831 |
| Exchange Rate Effect | -8,287 | -10,052 | -25,908 | -412 | 904 |
| Beginning Cash Position | 109,921 | 113,697 | 110,430 | 102,443 | 65,150 |
| End Cash Position | 692,888 | 935,327 | 1,101,820 | 109,515 | 69,644 |
| Net Cash Flow | $582,967 | $821,630 | $991,390 | $7,072 | $4,494 |
| Free Cash Flow | |||||
| Operating Cash Flow | 988,935 | 1,186,206 | 1,219,618 | -70,662 | -134,968 |
| Capital Expenditure | -5,052 | -2,587 | -1,959 | -911 | -1,458 |
| Free Cash Flow | 983,883 | 1,183,619 | 1,217,659 | -71,572 | -136,426 |